Altimmune, Inc.
For the period ended Dec 31, 2025. Filed Mar 6, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 6, 2026
ALT$1.94-8.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
4. Property and Equipment, Net
- Property and Equipment, Net
Property and equipment, net consists of the following (in thousands):
| | | | | | | |
|---|---|---|---|---|---|---|
| · · 2025 · · 2024 | ||||||
| Furniture, fixtures and equipment | | $164 | | 163 | ||
| Laboratory equipment | | 342 | | 342 | ||
| Computers and telecommunications | | 204 | | 194 | ||
| Software | | 178 | | 178 | ||
| Leasehold improvements | | 1,749 | | 1,749 | ||
| Property and equipment, at cost | | 2,637 | | 2,626 | ||
| Less: accumulated depreciation and amortization | | | (2,325) | | | (2,213) |
| Property and equipment, net | | $312 | | $413 | ||
Depreciation expense related to property and equipment for the years ended December 31, 2025 and 2024 was $0.1 million and $0.2 million, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.